InfuSystem is a rapidly growing healthcare services company that provides state-of-the-art electronic continuous ambulatory infusion pumps, supplies and support to oncology practices and clinics throughout the United States. More than 60% of oncologists across all 50 states turn to InfuSystem as their single, full-service source for cost-effective infusion pump management.
| Revenue (Most Recent Fiscal Year) | $134.86M |
| Net Income (Most Recent Fiscal Year) | $2.35M |
| PE Ratio (Current Year Earnings Estimate) | 36.20 |
| PE Ratio (Trailing 12 Months) | 40.13 |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 1.35 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 3.46 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 13.15 |
| Pre-Tax Margin (Trailing 12 Months) | 6.25% |
| Net Margin (Trailing 12 Months) | 3.63% |
| Return on Equity (Trailing 12 Months) | 9.11% |
| Return on Assets (Trailing 12 Months) | 4.90% |
| Current Ratio (Most Recent Fiscal Quarter) | 2.19 |
| Quick Ratio (Most Recent Fiscal Quarter) | 1.84 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.48 |
| Inventory Turnover (Trailing 12 Months) | 10.18 |
| Book Value per Share (Most Recent Fiscal Quarter) | $2.71 |
| Earnings per Share (Most Recent Fiscal Quarter) | $0.12 |
| Earnings per Share (Most Recent Fiscal Year) | $0.11 |
| Diluted Earnings per Share (Trailing 12 Months) | $0.23 |
| Exchange | NYSEMKT |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Common Shares Outstanding | 20.43M |
| Free Float | 18.34M |
| Market Capitalization | $188.53M |
| Average Volume (Last 20 Days) | 0.26M |
| Beta (Past 60 Months) | 1.79 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 10.20% |
| Percentage Held By Institutions (Latest 13F Reports) | 71.13% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |